Genencor

From Wikipedia, the free encyclopedia
Genencor International
TypePrivate
IndustryBiotechnology
Founded1982
HeadquartersPalo Alto, California, United States,
Palo Alto
Key people
Tjerk de Ruiter, Chairman & CEO
Michael Arbige, Vice President, Technology
Jim Sjoerdsma, Sr. Vice President, Human Resources
David Estell, Vice President, innovation
Products, ,
RevenueIncrease $380 Million USD (2005)
Number of employees
1,500 (2005)
ParentIFF
Websitehttp://biosciences.dupont.com//

Genencor is a biotechnology company based in Palo Alto, CA and a subsidiary of IFF.[1] Genencor is a producer of Industrial enzymes and low-priced bulk protein. The name Genencor originates with Genencor, Inc., the original joint venture between Genentech and Corning Incorporated, which was founded in 1982. It is considered to have pioneered the field of industrial biotechnology, as distinct from traditional applications of biotechnology to health care and agriculture.

In 2005 Genencor was acquired by Danisco.[2]

In 2008 Genencor entered a joint venture with DuPont, called DuPont Danisco Cellulosic Ethanol LLC, to develop and commercialize low cost technology for the production of cellulosic ethanol. In 2008, Genencor and Goodyear announced they were working to develop BioIsoprene.

In 2011, Dupont acquired [1]Danisco for $6.3 billion.

In 2021, portions of Dupont including the Genencor division were acquired by International Flavors & Fragrances.[3]

Awards[]

Genencor achieved the following awards:[citation needed]

  • Named No. 2 Best Medium-Sized Company to Work for in America by the Great Place to Work® Institute, Inc. (2004)
  • Named No. 1 Best Medium-Sized Company to Work for in America by the Great Place to Work® Institute, Inc. (2005)
  • Named No. 1 Best Place to Work in the Bay Area by the San Francisco Chronicle (2005)
  • Named No. 11 Best Medium-Sized Company to Work for in America by the Great Place to Work® Institute, Inc. (2011)

See also[]

References[]

  1. ^ Jump up to: a b DuPont. "DuPont to Acquire Danisco for $6.3 Billion". www.prnewswire.com. Retrieved 2019-07-11.
  2. ^ Danisco acquire Genencor for $419 million
  3. ^ "IFF to merge with DuPont's $26.2 billion nutrition unit". CNBC. 2019-12-16. Retrieved 2021-02-15.


Retrieved from ""